Form 4 for BMY Bristol Myers Squibb
Accepted 2022-11-09 00:00:00 ET · period of report 2022-11-07 · accession 0000014272-22-000198 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-09 | 2022-11-07 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $58.31 | +52.6K | 77.5K | +211% | +$3.07M |
| D | 2022-11-09 | 2022-11-07 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | S - Sale+OE | $78.88 | -45.9K | 57.1K | -45% | -$3.62M |
| DM | 2022-11-09 | 2022-11-07 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | -52.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2022-11-07 | M | A | 8,491 | $47.81 | 94,498 | D | — | — | |
| 2 | Common | Common Stock, $0.10 par value | 2022-11-07 | M | A | 8,491 | $38.41 | 102,989 | D | — | — | |
| 3 | Common | Common Stock, $0.10 par value | 2022-11-07 | S | D | 45,910 | $78.88 | 57,079 | D | — | — | (F1) 45,910 shares were sold to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $78.82 to $78.935, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock, $0.10 par value | 2022-11-07 | M | A | 5,843 | $70.89 | 56,228 | D | — | — | |
| 5 | Common | Common Stock, $0.10 par value | 2022-11-07 | M | A | 8,491 | $44.70 | 86,007 | D | — | — | |
| 6 | Common | Common Stock, $0.10 par value | 2022-11-07 | M | A | 21,288 | $72.42 | 77,516 | D | — | — | |
| 7 | Derivative | Option (right to buy) | 2022-11-07 | M | D | 8,491 | $0.00 | 0 | D | $47.81 · — to 2028-07-30 | 8,491 Common Stock, $0.10 par value | (F3) All of the shares are currently exercisable. |
| 8 | Derivative | Option (right to buy) | 2022-11-07 | M | D | 8,491 | $0.00 | 0 | D | $38.41 · — to 2028-10-29 | 8,491 Common Stock, $0.10 par value | (F3) All of the shares are currently exercisable. |
| 9 | Derivative | Option (right to buy) | 2022-11-07 | M | D | 5,843 | $0.00 | 0 | D | $70.89 · — to 2025-07-27 | 5,843 Common Stock, $0.10 par value | (F3) All of the shares are currently exercisable. |
| 10 | Derivative | Option (right to buy) | 2022-11-07 | M | D | 21,288 | $0.00 | 0 | D | $72.42 · — to 2027-07-31 | 21,288 Common Stock, $0.10 par value | (F3) All of the shares are currently exercisable. |
| 11 | Derivative | Option (right to buy) | 2022-11-07 | M | D | 8,491 | $0.00 | 0 | D | $44.70 · — to 2028-05-08 | 8,491 Common Stock, $0.10 par value | (F3) All of the shares are currently exercisable. |